Determination of trimethylbismuth in the human body after ingestion of colloidal bismuth subcitrate

Drug Metabolism and Disposition

Volumn 37, Issue 2, 2009, Pages 352-358

  Boertz, Jens ^a,b   Hartmann, Louise Michele ^a   Sulkowski, Margareta ^a   Hippler, Joerg ^a   Mosel, Frank ^b   Diaz Bone, Roland Arturo ^a   Michalke, Klaus ^a   Rettenmeier, Albert Wolfgang ^b   Hirner, Alfred Vitalis ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; CHEMICAL COMPOUND; METAL; TRIMETHYLBISMUTH; UNCLASSIFIED DRUG;

ABSORPTION; ADULT; AIR SAMPLING; ARTICLE; BIOTRANSFORMATION; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXCRETION; EXPIRED AIR; FECES; HUMAN; HUMAN EXPERIMENT; INGESTION; INTESTINE ABSORPTION; INTESTINE FLORA; LOW TEMPERATURE; MALE; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; PRIORITY JOURNAL; STOMACH ABSORPTION; URINALYSIS; URINE;

ADULT; BIOTRANSFORMATION; BODY MASS INDEX; FECES; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS;

EID: 59649083565     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.020313     Document Type: Article

References (33)

1. Aposhian HV and Aposhian MM (2006) Arsenic toxicology: five questions. Chem Res Toxicol 19:1-15.
2. Boertz J (2008) Investigation of bismuth metabolism via mass spectrometric techniques. Ph.D. thesis, University of Duisburg-Essen, Germany.
3. Chaleil D, Lefevre F, Allain P, and Martin GJ (1981) Enhanced bismuth digestive absorption in rats by some sulfhydryl compounds: NMR study of complexes formed. J Inorg Biochem 15:213-221.
4. Craig PJ (2003) Organometallic Compounds in the Environment, 2nd ed, John Wiley & Sons Ltd., Chichester, UK.
5. Diaz-Bone RA and Hitzke M (2008) Multi-element organometal(loid) speciation by hydride generation-GC-ICP-MS: overcoming the problem of species-specific optima by using a pH-gradient during derivatisation. J Anal At Spectrom 23:861-870.
6. Dopp E, Hartmann LM, Florea AM, Rettenmeier AW, and Hirner AV (2004) Environmental distribution, analysis and toxicity of organometal(loid) compounds. Crit Rev Toxicol 34:301-333.
7. Drobná Z, Waters SB, Walton FS, LeCluyse EL, Thomas DJ, and Stýblo M (2004) Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol Appl Pharmacol 201:166-177.
8. Feldmann J (1997) Summary of a calibration method for the determination of volatile metal(loid) compounds in environmental gas samples by using gas chromatography inductively coupled plasma mass spectrometry. J Anal At Spectrom 12:1069-1076.
9. Grüter UM, Kresimon J, and Hirner AV (2000) A new HG/LT-GC/ICP-MS multi-element speciation technique for real samples in different matrices. Fresenius J Anal Chem 368:67-72.
10. Hirner AV and Emons H, eds (2004) Organic Metal and Metalloid Species in the Environment: Analysis, Distribution, Processes and Toxicological Evaluation, Springer, Berlin.
11. Hirner AV, Hartmann LM, Hippler J, Kresimon J, Koesters J, Michalke K, Sulkowski M, and Rettenmeier AW (2004) Organometal(loid) compounds associated with human metabolism, in Organic Metal and Metalloid Species in the Environment: Analysis, Distribution, Processes and Toxicological Evaluation (Hirner AV and Emons H eds) pp 181-203, Springer, Berlin.
12. Klotz U (2000) Pharmacokinetic considerations in the eradication of Helicobacter pylori. Clin Pharmacokinet 38:243-270.
13. Koesters J, Hippler J, Diaz-Bone RA, and Hirner AV (2005) Parallel ICP-MS and EI-MS detection after GC separation as a unique tool for simultaneous identification and quantification of volatile heteroatomic organic compounds. J Anal At Spectrom 9:996-999.
14. Lowe DJ (1974) Adverse effects of bismuth subgallate: a further report from the Australian Drug Evaluation Committee. Med J Aust 2:664-666.
15. Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, Kopplin MJ, Cebrián ME, Silbergeld EK, and Aposhian HV (2003) Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem Res Toxicol 16:1507-1513.
16. Martin-Bouyer G (1978) Poisoning by orally administered bismuth salts. Gastroenterol Clin Biol 2:349-356.
17. Menge H, Gregor M, Brosius B, Hopert R, and Lang A (1992) Pharmacology of bismuth. Eur J Gastroenterol Hepatol 4:41-47.
18. Michalke K, Meyer J, and Hensel R (2007) Methylation of metal(loid)s by methanoarchaea: production of volatile derivatives with high ecotoxicological impact and health concern, in Archaea: Evolution, Physiology, and Molecular Biology (Garrett RA and Klenk HP eds) pp 285-293, Blackwell Publishing, Boston.
19. Michalke K, Meyer J, Hirner AV, and Hensel R (2002) Biomethylation of bismuth by the methanogen Methanobacterium formicicum. Appl Organomet Chem 16:221-227.
20. Michalke K, Schmidt A, Huber B, Meyer J, Sulkowski M, Hirner AV, Boertz J, Mosel F, Dammann P, Hilken G, et al. (2008) The role of intestinal microbiota in the transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice. Appl Environ Microbiol 74:3069-3075.
21. Michalke K, Wickenheiser EB, Mehring M, Hirner AV, and Hensel R (2000) Production of volatile derivatives of metal(loid)s by microflora involved in anaerobic digestion of sewage sludge. Appl Environ Microbiol 66:2791-2796.
22. Nwokolo CU, Lewin JF, Hudson M, and Pounder RE (1992) Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology 102:163-167.
23. Nwokolo CU, Prewett EJ, Sawyerr AM, Hudson M, and Pounder RE (1991) The effect of histamine-H2-receptor blockade on bismuth absorption from 3 ulcer-healing compounds. Gastroenterology 101:889-894.
24. Slikkerveer A and de Wolff FA (1989) Pharmacokinetics and toxicity of bismuth compounds. Med Toxicol Adverse Drug Exp 4:303-323.
25. Styblo M, Del Razo LM, LeCluyse EL, Hamilton GA, Wang C, Cullen WR, and Thomas DJ (1999) Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem Res Toxicol 12:560-565.
26. Sun H, Zhang L, and Szeto KY (2004) Bismuth in medicine. Mel Ions Biol Syst 41:333-378.
27. Thayer JS (2002) Biological methylation of less-studied elements. Appl Organomet Chem 16:677-691.
28. Tietz NW (1995) Clinical Guide to Laboratory Tests, 3rd ed, pp 186 -187, WB Saunders Company, Philadelphia.
29. Treiber G, Walker S, and Klotz U (1994) Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate. Clin Pharmacol Ther 55:486-491.
30. Wickenheiser EB, Michalke K, Drescher C, Hirner AV, and Hensel R (1998) Development and application of liquid and gas-chromatographic speciation techniques with element specific (ICP-MS) detection to the study of anaerobic arsenic metabolism. Fresenius J Anal Chem 362:498-501.
31. Williams DR (1977) Analytical and computer simulation studies of colloidal bismuth citrate system used as an ulcer treatment. J Inorg Nucl Chem 39:711-714.
32. Yu D (1999) A physiologically based pharmacokinetic model of inorganic arsenic. Regul Toxicol Pharmacol 29:128-141.
33. Zhang J, Lu R, Gu Z, and Zhou G (2006) Inter-effect of toxicity on the combined medication of amoxicillin, metronidazole and colloidal bismuth subcitrate. Zhongguo Yaoke Daxue Xuebao 37:559-561.